Surrey Heartlands

Joint Formulary & PAD

Botulinum toxin type A - Protective ptosis and squint

You are here : Home > Formulary Search > Botulinum toxin type A - Protective ptosis and squint

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important

NOTE; different brands of botulinum toxin have difference licenses, please check SmPC.

RSFT: Opthalmology Only

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Botulinum toxin type A
Indication :
Protective ptosis and squint
Group Name :
Keywords :
Brand Names Include :
Botox
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Botulinum toxin type A is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Protective ptosis and squint.

  • No records returned.

Committee Recommendations (1)

02 Oct 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.